Home Drugs Page 33

Drugs

Advair Diskus 500 50

Advair Diskus 500 50

A brief guide to Advair Diskus 500 50

Patients whose asthma symptoms are extremely severe may be assigned Advair 500 50 Diskus to temporarily supplement their long-term medication. This medication is solely intended for short-term asthma use–Asthmatics face an increased risk of death if treatment with Advair 500 is prolonged. It is important to closely monitor all adverse effects when taking Advair Diskus 500 50 to safeguard your health.

Advair 500 50 Diskus is the strongest possible dose of the medication. If a physician prescribes you Advair 500 50 Diskus, treatment will begin with 100 mg applications. Should this not prove effective, your dosage will be increased to 250 mg. If no alleviation of symptoms is achieved, your dosage will bump-up to the maximum 500 50 level.

A physician will carefully observe whether your most troublesome symptoms are alleviated by use of Advair Diskus 500 50. Once these are under control, a plan is created to reduce your use of Advair 500 50 Diskus to a smaller dose. Eventually, use of the drug should be discontinued to avoid adverse reactions or asthma-related deaths.

While this medication has been proven effective for long-term use in patients with emphysema or bronchitis in the 250 mg form, clinical studies have not proven Advair Diskus 500 50 to be useful for people suffering from such diseases. Therefore, patients with emphysema will not be assigned Advair 500 50 Diskus.

In addition to asthma-related deaths, Advair 500 use poses other dangers risks. If you experience even minor discomfort from the use of Advair Diskus 500 50, report these symptoms to a doctor. Be alert to signs of allergic reactions, including swelling, rashes and hives. If you are short of breath after taking Advair 500 and your emergency inhaler is not of help, seek emergency care.

Advair Diskus 500 50 is not intended for relief of emergency symptoms. If you are having trouble breathing, do not take an extra dose of Advair 500 50 Diskus. By doing so, you increase the risk of serious side effects.

Your physician should be clear about the potential risks involved in taking Advair Diskus 500 50. Additionally, guidelines that accompany Advair 500 50 Diskus will explain how to minimize the risk of serious medical responses. Be sure to closely follow doctor’s orders when taking Advair 500.

Contact a lawyer if you feel that your physician may have been negligent in supervising your use of Advair Diskus 500 50. You will not be able to sue for compensation if these occurred after you disregarded a doctor's instructions.

 

Classification of Drugs

Classification of Drugs

How are Drugs classified in the United States?
 
 
Drugs are classified in the United States depending on the substance’s inherent characteristics and the side effects present following administration. All drugs are classified in an organized and detailed fashion in the United States, through the passing of the Controlled Substances Act of 1970. This legislation represented the introduction of a major illegal substance control campaign. Each drug is classified under a certain schedule depending on the intended use of the substance and the dangers imposed. 
 
 
Additionally, the drugs are classified based on their potential for abuse. For instance, cocaine or heroine, common street drugs that impose brutal side effects and possess a high degree of potential abuse or addiction are regarded as the most deadly drugs in the country. 
 
 
As a result of these characteristics, these substances are labeled as Schedule I drugs and accordingly possess the most stringent and severe punishments in regards to possession, use and the intent to distribute. That being said, the severity of punishment associated with all classifications of drugs is dependent on the quantity of the drug and whether the individual in possession has intent to sell or distribute the drugs—intent to sell carries a far greater punishment than simply possessing the drug. 
 
 
Drug Classification in the United States According to the Controlled Substances Act:
 
 
Schedule 1 Drugs: 
 
 
These substances are regarded as the deadliest drugs in society in regards to potential for abuse and adverse side effects. The drugs listed in schedule also possess no accepted medical benefit or use of treatment in the United States. Drugs listed in Schedule 1 also contain a lack of accepted safety in regards to use of the drug. Those drugs listed in Schedule 1 include heroine, cocaine, Acid and Crack.
 
 
Schedule II Drugs:
 
 
Encompasses any drug or other substance that has a high potential for abuse and possesses a currently accepted medical use in treatment in the United States. Drugs in this classification, when abused, may lead to severe physical or psychological dependence. Morphine is an example of a Schedule II drug
 
 
Schedule III Drug:
 
 
Refers to any drug or other substance that has a potential for abuse less than the drugs or substances listed in schedules I and II. Drugs or substances in Schedule III are currently accepted as forms of medically treatment in the United States. Abusing such drugs or substances in this classification may lead to moderate or low physical or high psychological dependence.
 
 
Schedule IV Drugs: 
 
 
Drugs in this category possess a low potential for abuse relative to the drugs or substances listed in schedule III. The drugs or substance has a currently accepted medical use in treatment in the United States and abuse of such drugs may lead to limited physical dependence or psychological dependence relative to the substances in schedule III
 
 
Schedule V Drugs:
 
 
Drugs listed in this category have a low potential for abuse relative to the drugs or substances in schedule IV. The drugs or substances in Schedule V have an accepted medical use in treatment in the United States and abuse of the substances may lead to limited to physical dependence or physiological dependence relative to the drugs or substances listed in schedule IV.
 

Triaminic Vapor Patch

Triaminic Vapor Patch

What is the Triaminic Vapor Patch?
The Triaminic Vapor patch is a cough suppressant developed and manufactured by Novartis.  The Vapor Patch is applied to the throat and chest and works by allowing vapors from the patch to enter the nose and throat.  The patch consists of camphor, eucalyptus oil and menthol and is available for children aged 2 years and older.  In 2006 Novartis volunatarily recalled the Vapor Patch after it was found that children could suffer serious side effects if the patch was removed and ingested.
Side effects
Used as prescribed the Triaminic Vapor Patch is relatively safe and the side effects include blisterin, scarring, bruising, headache, and depigmentation of the skin, hair, or eyes.  Serious side effects occur when the Vapor Patch is swallowed.   The active ingredients, camphor and eucalyptus oil can have severe effects if swallowed.  This includes burning feeling in the mouth, nausea, headaches, vomiting and seizure.
Recall
In 2006 after a report that a child suffered a seizure after swallowing a Triaminic Vapor Patch Novartis issued a voluntary recall of the product with the knowledge of the FDA.